KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) Preferred Dividend Payments (2023 - 2025)

Evolent Health (EVH) has 3 years of Preferred Dividend Payments data on record, last reported at $6.1 million in Q3 2025.

  • For Q3 2025, Preferred Dividend Payments fell 25.06% year-over-year to $6.1 million; the TTM value through Sep 2025 reached $52.7 million, up 64.69%, while the annual FY2024 figure was $31.8 million, 8.94% up from the prior year.
  • Preferred Dividend Payments reached $6.1 million in Q3 2025 per EVH's latest filing, down from $31.2 million in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $31.2 million in Q2 2025 and bottomed at $6.1 million in Q3 2025.
  • Average Preferred Dividend Payments over 3 years is $9.6 million, with a median of $7.9 million recorded in 2023.
  • The widest YoY moves for Preferred Dividend Payments: up 290.94% in 2025, down 25.06% in 2025.
  • A 3-year view of Preferred Dividend Payments shows it stood at $8.0 million in 2023, then fell by 2.14% to $7.8 million in 2024, then dropped by 22.36% to $6.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Preferred Dividend Payments were $6.1 million in Q3 2025, $31.2 million in Q2 2025, and $7.6 million in Q1 2025.